InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Keyser d Jeffrey, Director. Director active across 1 company, notably Lantern Pharma Inc.. Cumulatively, 2 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €85k. Activity tracked since 24 July 2024. The latest transaction was filed on 12 May 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Keyser d Jeffrey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
48,544 股@ US$2.060.21% mcap50.0% 占其流量Common stock, $0.001 par valueSEC:0001493152-26-023082:0
标准退出：2026年8月10日 (T+90)
3,832 股@ US$3.136.1% 占其流量Common stockSEC:0001493152-24-029238:0
2 条申报中的 2 条
About Keyser d Jeffrey
Jeffrey D. Keyser serves as a Board Member of Lantern Pharma Inc. He participates in the governance of the company by overseeing operations and contributing to strategic decision-making. His role is essential in ensuring compliance and transparency in the company's activities.
